P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.

NCT01591421 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: BKM120
DRUG: Panitumumab

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]